澳洋健康(002172.SZ)控股股东将变更为悦升科技 9月16日起复牌

Core Viewpoint - The announcement reveals that Aoyang Health's controlling shareholder, Aoyang Group, is transferring 20% of its shares, totaling 153 million shares, to Yue Sheng Technology at a price of 3.87 RMB per share, amounting to a total transaction value of 593 million RMB [1] Group 1 - Aoyang Group will no longer be the controlling shareholder and actual controller of Aoyang Health after the share transfer [1] - Yue Sheng Technology will become the new controlling shareholder, with the Zhangjiagang Economic and Technological Development Zone Management Committee as the actual controller of the company [1] - The company's stock will resume trading on September 16, 2025 [1]